Total Valuation
Pro Medicus Limited has a market cap or net worth of $13.07B. The enterprise value is $21.04K.
Market Cap$13.07B
Enterprise Value$21.04K
Share Statistics
Pro Medicus Limited has 104,469,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding104,469,960
Owned by Insiders46.92%
Owned by Institutions0.08%
Financial Efficiency
Pro Medicus Limited’s return on equity (ROE) is 0.59 and return on invested capital (ROIC) is 24.67%.
Return on Equity (ROE)0.59
Return on Assets (ROA)0.43
Return on Invested Capital (ROIC)24.67%
Return on Capital Employed (ROCE)0.35
Revenue Per Employee1.71M
Profits Per Employee1.73M
Employee Count153
Asset Turnover0.43
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pro Medicus Limited is 68.5. Pro Medicus Limited’s PEG ratio is 0.61.
PE Ratio68.5
PS Ratio81.22
PB Ratio47.13
Price to Fair Value47.13
Price to FCF156.19
Price to Operating Cash Flow133.11
PEG Ratio0.61
Income Statement
In the last 12 months, Pro Medicus Limited had revenue of 261.69M and earned 265.34M in profits. Earnings per share was 2.54.
Revenue261.69M
Gross Profit211.15M
Operating Income196.12M
Pretax Income377.52M
Net Income265.34M
EBITDA204.18M
Earnings Per Share (EPS)2.54
Cash Flow
In the last 12 months, operating cash flow was 136.52M and capital expenditures -444.00K, giving a free cash flow of 136.08M billion.
Operating Cash Flow136.52M
Free Cash Flow136.08M
Free Cash Flow per Share1.30
Dividends & Yields
Pro Medicus Limited pays an annual dividend of $0.266, resulting in a dividend yield of 0.35%
Dividend Per Share$0.266
Dividend Yield0.35%
Payout Ratio24.80%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.34
52-Week Price Change-38.57%
50-Day Moving Average128.10
200-Day Moving Average117.06
Relative Strength Index (RSI)42.24
Average Volume (3m)129.00
Important Dates
Pro Medicus Limited upcoming earnings date is Feb 16, 2027, TBA (Confirmed).
Last Earnings DateAug 17, 2026
Next Earnings DateFeb 16, 2027
Ex-Dividend Date―
Financial Position
Pro Medicus Limited as a current ratio of 6.82, with Debt / Equity ratio of 0.49%
Current Ratio6.82
Quick Ratio6.82
Debt to Market Cap<0.01
Net Debt to EBITDA-0.71
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pro Medicus Limited has paid 112.17M in taxes.
Income Tax112.17M
Effective Tax Rate0.30
Enterprise Valuation
Pro Medicus Limited EV to EBITDA ratio is 103.39, with an EV/FCF ratio of 155.13.
EV to Sales80.67
EV to EBITDA103.39
EV to Free Cash Flow155.13
EV to Operating Cash Flow154.62
Balance Sheet
Pro Medicus Limited has $250.62M in cash and marketable securities with $2.23M in debt, giving a net cash position of $248.39M billion.
Cash & Marketable Securities$250.62M
Total Debt$2.23M
Net Cash$248.39M
Net Cash Per Share$2.38
Tangible Book Value Per Share$4.10
Margins
Gross margin is 80.69%, with operating margin of 74.94%, and net profit margin of 101.40%.
Gross Margin80.69%
Operating Margin74.94%
Pretax Margin144.26%
Net Profit Margin101.40%
EBITDA Margin78.02%
EBIT Margin74.94%
Analyst Forecast
The average price target for Pro Medicus Limited is $158.04, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$158.04
Price Target Upside21.24% Upside
Analyst ConsensusModerate Buy
Analyst Count10
Revenue Growth Forecast29.23%
EPS Growth Forecast139.45%